Duke University School of Medicine acknowledge faculty members who were selected as recipients of this year’s School of Medicine faculty awards.
Duke Health is leading its first clinical trial under a large federal initiative to develop a new-generation flu vaccine.
When the COVID-19 pandemic began in 2020, faculty members in Duke Surgery’s Division of Surgical Sciences quickly joined the efforts to develop a vaccine against SARS-CoV-2.
A $6.6M endowed gift by Marion Stein, MD, in memory of her late husband, Norm Letvin, MD, & in honor of Bart Haynes, MD, will significantly advance new vaccine development + therapies for HIV/A
The Duke Human Vaccine Institute has received a federal contract to manufacture a pan-coronavirus vaccine candidate that can be tested in a phase 1 clinical trial.
As chief operating officer at the Duke Human Vaccine Institute (DHVI),
Despite more than 40 years of research since its discovery, HIV remains a chronic disease that impacts millions of people.